HSP90AB1 and breast carcinoma: Concerning compounds, the results showed that different classes of plant-based compounds, including diarylheptanoids, diterpenoids, flavonoids, phenylethanoids, secoiridoids, and withanolides, can inhibit the HSP90 activity and modulate its downstream signaling pathways in breast cancer.